PGY2 PROGRAM
Residency Program Director
-
Mike Boyd, PharmD, BCCP, BCPS
- PGY2 Cardiology Residency Program Director, The Ohio State University Wexner Medical Center
- Specialty Practice Pharmacist, Cardiology/Electrophysiology
- Residency: Adult Medicine, St. Louis College of Pharmacy
- PharmD: University of Cincinnati College of Pharmacy
Previous Year Residents
-
Anthony Ross, PharmD, BCPS
CVICU Clinical Pharmacy Specialist - Cleveland Clinic -
Jessica Brumit, PharmD, MBA, BCPS
Cordiology Pharmacy Specialist - Johnson City Medical Center -
Ryan Caputo, PharmD
Staff Pharmacist, Indiana University Health, Indianapolis, IN -
Kushal Naik, PharmD, MBA
Clinical Pharmacist, CV ICU, Cleveland Clinic, Cleveland, OH -
Rachel Klosko
Clinical Assistant Faculty Member, Binghamton School of Pharmacy, Binghamton, New York -
Rachael Eaton
Clinical Pharmacy Specialist- Vascular Surgery, The Ohio State Wexner Medical Center -
Rachel Lavelle
Clinical Pharmacy Specialist – Cardiology, University of Chicago Medicine, Chicago, IL -
Daniel Galipeau
Cardiology Clinical Pharmacist, UK HealthCare, Lexington, Kentucky -
Sara Johnson
Cardiology Clinical Pharmacist, The University of Kansas Health System -
Maya Holsen
Cardiology Critical Care Specialty Pharmacist and Faculty, University of Buffalo -
Joshua Jacobs
Cardiology Clinical Pharmacist, The University of Utah -
Shea Macielak
Cardiothoracic Surgery Clinical Pharmacist, Mayo Clinic, Rochester, MN -
Poonam Jewani
Clinical Pharmacy Specialist, Cardiology, MD Anderson Cancer Center, Houston, TX -
Brooke Stanton
Clinical Specialist – Cardiology/Critical Care, SSM Health, St. Louis University Hospital, St. Louis, MO -
Libby Orzel
Medical Science Liaison, Sanofi -
Christopher Min
Medical Science Liaison, Sanofi -
Heidi Brink
Pharmacy Coordinator, Cardio/Pulmonary Transplant, Nebraska Medical Center -
Bola Lawuyi
Cardiology Clinical Specialist , Medstar Washington Hospital, Washington DC
About the PGY2 Cardiology Residency Program
Residency Sites
As one of America’s top ranked academic medical centers, the mission of The Ohio State University Wexner Medical Center (OSUWMC) is to improve people’s lives through innovation in research, education, and patient care.
OSUWMC is a 1,506 bed multi-hospital delivery system recognized in 2018 as one of “America’s Best Hospitals” for excellence in ten specialties by US News and World Report based on quality, outcomes, and reputation.
The Ross Heart Hospital
The Richard M. Ross Heart Hospital at The OSUWMC is a 150-bed, comprehensive, cardiovascular center which specializes in the multidisciplinary care of patients in areas of cardiovascular surgery, heart failure, pulmonary hypertension, heart and lung transplant , acute coronary syndromes, mechanical circulatory support and electrophysiology. Each floor is dedicated to a specific service and combines the latest technology with patient –focused care to create the best possible healing environment. Our staff manages patients across a diverse spectrum of care, extending from critical care to the ambulatory setting. Ohio State’s Heart and Vascular Center is considered one of the nation’s best hospitals for cardiology and heart surgery, as ranked by U.S. News & World Report, the only central Ohio hospital to earn a spot on the list. Our philosophy strongly supports working as a team to provide the right care to the right patient at the right time, in a safe and secure environment.
KEY ROTATIONS/EXPERIENCES
The OSUMC has many opportunities for rounding on a cardiology-based service. The residents will be responsible for participation in clinical pharma
cy rounding services with direct patient care responsibilities in a variety of settings. Most of the services are teaching services and may be composed of an attending physician, a fellow, and house staff (including residents, interns, and advanced practice providers). The resident will strengthen his/her clinical acumen and communication skills through completing at least one rotation on each required service. The remaining rotations will be determined based on the resident’s goals and the discretion of the residency program director.
Required Learning Experiences (4-5 weeks in duration unless noted otherwise):
- General Cardiology
- Acute Coronary Syndromes/Coronary Intensive Care
- Heart Failure/Heart Transplant
- Cardiovascular Intensive Care Unit
- Thoracic Transplant
- Electrophysiology (2 weeks)
Sample Elective Learning Experiences (2-5 weeks in duration):
- Cardiovascular Ambulatory Care
- Neurocritical Care
- Advanced rotation in any of the required learning experiences
Key Preceptors
Danielle Blais, PharmD, BCCP, BCPS
Acute Coronary Syndrome/Coronary Intensive Care
Mike Boyd, PharmD, BCCP, BCPS
Electrophysiology/ Cardiology
Pam Burcham, PharmD, BCTXP, BCPS
Thoracic Transplant
Rachael Eaton, PharmD, BCCP
Vascular Surgery
Kevin Kissling, PharmD, BCPS
Heart Failure/Heart Transplant
Kerry Pickworth, PharmD, FCCP
Heart Failure/Heart Transplant
Alan Rozycki, PharmD, BCCCP
Cardiovascular Intensive Care Unit
Selected Resident Research
- Incidence and time to cytomegalovirus disease in cardiac transplant recipients receving induction immunosuppression with antithymocyte globulin- Jewani P, Kissling K
- Sotalol initiation in patients with a prolonged corrected QT interval: experiences from an academic medical center- Stanton B, Boyd JM
- Risk factors associated with subtherapeutic anticoagulation with Bivalirudin – Herman L
- Switching From Ticagrelor to Clopidogrel: Outcomes after Percutaneous Coronary Intervention-Min C
- Comparison of the safety of adenosine and regadenoson in outpatient cardiac stress testing. Pharmacother 2015;35(12):1117-1123.- Brink H, Dickerson J, Stephens J, Pickworth K
- Desensitization as an approach to the clinical conundrum of cardiovascular patients with aspirin allergy-Lawuyi B, Blais D
- Thirty day hospital readmission for thromboembolic complications in patients with potential heparin-induced thrombocytopenia- Kazmi H, Kissling K, Abel E
- Efficacy of prophylactic oral amiodarone and intravenous magnesium in decreasing the incidence of post-operative atrial fibrillation in cardiac surgery- Varnado S, Burcham P, Blais D, Abel E
Benefits and Additional Requirements
Application Deadline: January 2, 2021
We welcome applications from non-U.S. citizens who have a “green card” (permanent resident status) or a current visa valid through the entire duration of the residency program. The Ohio State University pharmacy residency programs are NOT able to sponsor visas for pharmacy residents (PGY1 or PGY2).
Start Date: July 1
Annual Salary – $50,500
Vacation Days – 10 days
Staffing Requirement – 20 weekends a year
Completion of a Major Research Project
You must be logged in to post a comment.